Medsn Enhances Doctor-Patient Relationship with InforMedix Partnership

Alliance Provides Services to Pharmaceutical and Biotech Industries

Los Angeles, CA-December 12, 2002 -- Medsn, Inc. the premiere interactive medical marketing and education solutions firm, has entered into a strategic alliance with InforMedix, Inc. to market the Med-eMonitorä System, to support Phase IV clinical trials and Medsns compliance and persistency programs. The alliance is targeting the pharmaceutical and biotechnology industries.

The Med-eMonitorä System provides real-time information to patients, caregivers, and healthcare professionals. The portable Med-eMonitorä device converts the patient's clinical drug protocols, or medical treatment plans, into an automated sequence of prompted and recorded events. The Med-eMonitorä System assists patients in taking their medications and improves medication compliance and persistence. It accomplishes this by indicating to patients when to take their medications, which medications to take, the proper amounts, and by providing other health information throughout the day to enable better health management. The Med-eMonitorä System is linked to an Internet-accessible database that remotely controls the device and reports patient data.

We are fortunate to be part of this exciting technology. The daily data gathered by the Med-eMonitorä will monitor and report patient outcomes, improve medication compliance and persistence, enable rapid and targeted patient management interventions, and speed time-to-market of new pharmaceutical agents. This is critical to the success of our pharmaceutical customers and ultimately a tremendous benefit to patients and their families." said Dennis Bonilla, CEO of Medsn.

The Med-eMonitorÔ System can identify a variety of medication errors that have recently become the focus of the healthcare industry. The Med-eMonitorä System interacts with the patient time and date stamping each interaction, and stores the patient's medication use and health status data. It can also store data from physiologic monitors that assess heart functions, lung functions, blood pressure, glucose and other vital functions.

Bruce A. Kehr, M.D., Chairman and CEO of InforMedix, said, We are pleased to have Medsn as a marketing partner. Medsn has been recognized as an industry leader for medical marketing and education solutions for pharmaceutical sales and marketing professionals. The initial promotional thrust will focus on the R&D market (clinical trials/clinical investigators) where Medsn will assist InforMedix with launching the Med-eMonitorä System to sales and marketing teams in the healthcare industry. We are confident in Medsn's abilities to penetrate this market by building upon their success of the previous 18 months and in securing an impressive array of new clients in the pharmaceutical, biotechnology, and medical device sectors."

About Medsn

Medsn is the premier interactive Medical Marketing Solutions Company that designs and implements customized programs for pharmaceutical, medical device, biotechnology and health care organizations. Medsn focuses exclusively on healthcare and employs an in-house staff of physicians, marketing experts, industry executives, medical illustrators and technology specialists who possess unique expertise in effectively leveraging interactive multimedia technologies to develop high-impact programs that influence the behavior of physicians, health care professionals and patients, as well as pharmaceutical and medical device sales representatives.

Medsn is recognized within the healthcare industry for its in-depth medical and life sciences domain knowledge, state-of-the-art learning platform and proven project management expertise. Medsn delivers proven ROI through efficient, effective behavior-changing solutions.

Key academic advisors at premier institutions support the company, including Yale, Johns Hopkins, UC San Francisco, Oxford and Cambridge, as well as leading experts in the fields of sales and marketing, communications and learning.

About InforMedix, Inc.

Founded in 1997, InforMedix, Inc., located in Rockville, Maryland, has developed, patented and integrated a portable patient monitoring device, hardware, and software and network communications system to enable pharmaceutical firms, medical researchers and physicians to efficiently monitor and manage patients medication compliance and clinical responses. The Med-eMonitor leverages the companys rich patent portfolio of 15 issued and 18 pending patents.

InforMedix is launching its product after successfully placing working beta units in pilot sites to validate efficacy and secure endorsements, references and white papers. InforMedix has established an active Board of Directors and Advisory Board comprised of nationally recognized experts.